A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/08/2009	CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009	CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof
12/08/2009	CA2386720C Alcohol based topical anesthetic formulation and method
12/08/2009	CA2383054C Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
12/08/2009	CA2381801C Phosphonic acid derivative having inhibitory activity against carboxypeptidase b
12/08/2009	CA2378557C Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
12/08/2009	CA2375986C Substituted pyrazole compounds
12/08/2009	CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009	CA2373183C Iminocyclitol inhibitors of hexoaminidase and glycosidase
12/08/2009	CA2370230C Treatment of systemic lupus erythematosis
12/08/2009	CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/08/2009	CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/08/2009	CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use
12/08/2009	CA2355075C Heteroaryl-cyclic acetals
12/08/2009	CA2347907C Formulations for topical application of substances having an antiandrogenic action
12/08/2009	CA2340952C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
12/08/2009	CA2333475C Derivatives of pyrazolines, their preparation and their application as medicaments
12/08/2009	CA2333076C Topical application of muscarinic analgesic drugs such as neostigmine
12/08/2009	CA2329046C Composition comprising l-ascorbic acid and pectin
12/08/2009	CA2322865C Pharmaceutical compositions for ulcer
12/08/2009	CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide
12/08/2009	CA2315113C Pyridones as src family sh2 domain inhibitors
12/08/2009	CA2314613C Azolo triazines and pyrimidines
12/08/2009	CA2302496C Urinary incontinence therapy
12/08/2009	CA2302275C Solid solution beadlet
12/08/2009	CA2296742C Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
12/08/2009	CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/08/2009	CA2266584C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/08/2009	CA2265696C Method for purifying gbs toxin/cm101
12/08/2009	CA2218116C Pulmonary delivery of aerosolized medicaments
12/08/2009	CA2202016C Process for the production of lipstatin and of tetrahydrolipstatin
12/08/2009	CA2136871C Composition and method for inducing satiety
12/05/2009	CA2635187A1 Oligonucleotide duplexes and uses thereof
12/05/2009	CA2632926A1 Solubilized benzoyl peroxide topical drug formulation for treatment of acne
12/03/2009	WO2009146408A1 Methods for using tgf-b receptor inhibitors or activin-like kinase (alk) 5 inhibitors a-83-01 and sb-431542 to treat eye disease and wound healing conditions
12/03/2009	WO2009146406A1 Purine pi3k inhibitor compounds and methods of use
12/03/2009	WO2009146365A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists
12/03/2009	WO2009146358A1 Imidazopyridine and related analogs as sirtuin modulators
12/03/2009	WO2009146347A1 Hepatitis c virus inhibitors
12/03/2009	WO2009146325A1 Polymorphic and amorphous forms of lacosamide and amorphous compositions
12/03/2009	WO2009146320A1 Therapeutic methods and compounds
12/03/2009	WO2009146310A1 Deuterated tizanidine
12/03/2009	WO2009146288A1 Processes and compounds for the preparation of normorphinans
12/03/2009	WO2009146255A1 Prostaglandin produgs as hypotensive agents
12/03/2009	WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use
12/03/2009	WO2009146216A2 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
12/03/2009	WO2009146183A1 Methods to produce rod-derived cone viability factor (rdcvf)
12/03/2009	WO2009146182A1 Trpv4 antagonists
12/03/2009	WO2009146177A1 Trpv4 antagonists
12/03/2009	WO2009146144A2 Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator
12/03/2009	WO2009146131A2 Compositions for prevention/prophylactic treatment of poison ivy dermatitis
12/03/2009	WO2009146123A2 Compositions and methods for treating viral infections
12/03/2009	WO2009146102A1 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
12/03/2009	WO2009146097A1 Raloxifene pharmaceutical formulations
12/03/2009	WO2009146034A2 Mapk/erk kinase inhibitors and methods of use thereof
12/03/2009	WO2009146033A2 Compositions and methods for modulating smn activity
12/03/2009	WO2009146031A1 Methods of treating disease-induced ataxia and non-ataxic imbalance
12/03/2009	WO2009146030A1 Methods and systems for reducing inflammation by neuromodulation of t-cell activity
12/03/2009	WO2009145996A2 Amide derivatives as positive allosteric modulators and methods of use thereof
12/03/2009	WO2009145982A1 Compositions and methods for skin care
12/03/2009	WO2009145921A1 Method and composition for skin inflammation and discoloration
12/03/2009	WO2009145900A1 Methods and compositions for sleep disorders and other disorders
12/03/2009	WO2009145899A1 5-substituted isoindoline compounds
12/03/2009	WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	WO2009145852A1 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
12/03/2009	WO2009145841A1 Compositions and methods for immunotherapy
12/03/2009	WO2009145839A1 Polyamine compounds that bind tar rna of hiv and methods of treating viral disorders
12/03/2009	WO2009145831A1 Treatment of the idiopathic nephrotic syndrome spectrum diseases using basiliximab
12/03/2009	WO2009145816A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/03/2009	WO2009145814A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/03/2009	WO2009145751A1 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
12/03/2009	WO2009145721A1 Isoindoline derivatives comprising phenyl groups and their use in the treatment of pain disorders
12/03/2009	WO2009145720A1 Isoindoline derivatives comprising additional heterocyclic groups and their use in the treatment of pain disorders
12/03/2009	WO2009145719A1 Isoindoline derivatives comprising a cyano group and their use in the treatment of pain disorders
12/03/2009	WO2009145718A1 Isoindoline derivatives comprising an additional heterocyclic group and their use in the treatment of pain disorders
12/03/2009	WO2009145716A1 New pharmaceutical formulation useful in gerd therapy
12/03/2009	WO2009145619A1 Antibiotic composition
12/03/2009	WO2009145591A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
12/03/2009	WO2009145590A2 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
12/03/2009	WO2009145557A2 Use of physcion-8-o-beta-d-glucopyranoside or physcion for promoting osteoblast activity
12/03/2009	WO2009145424A2 Anti-peptic ulcer composition comprising rice prolamin
12/03/2009	WO2009145368A1 Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
12/03/2009	WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	WO2009145358A2 Medicament for the prophylaxis or treatment of hypertension
12/03/2009	WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva
12/03/2009	WO2009145356A1 Method and composition for treating ocular hypertension and glaucoma
12/03/2009	WO2009145300A1 External preparation for skin
12/03/2009	WO2009145299A1 Ceramide dispersion
12/03/2009	WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009	WO2009145286A1 Heterocyclic compound
12/03/2009	WO2009145269A1 Transdermal preparation
12/03/2009	WO2009145243A1 Lipid membrane applicable to photodynamic therapy and application thereof
12/03/2009	WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009	WO2009145177A1 Donepezil-containing patch preparation and packaging thereof
12/03/2009	WO2009145171A1 Novel benzothiophene oxide derivative and salt thereof
12/03/2009	WO2009145067A1 Therapeutic agent for pain and use thereof
12/03/2009	WO2009144977A1 Oral composition for hair growth
12/03/2009	WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009	WO2009144738A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
12/03/2009	WO2009144736A1 NOVEL PROCESS FOR THE PREPARATION OF 4-FLUORO-ALPHA-[2-METHYL -1-OXOPROPYL]-GAMMA-OXO-N-ß-DIPHENYLBENZENEBUTANAMIDE AND PRODUCTS THEREFROM

1 ... 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 ... 7860